Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics: Jens Ravens, Hansjörg Plaggemars

Jens Ravens has left the executive board of Berlin-based Epigenomics after the company transferred almost all of its assets to New Day Diagnostics. He initially served as the firm's CFO and took on other executive functions after CEO Greg Hamilton left in June of 2023. Starting May 1, Hansjörg Plaggemars will manage Epigenomics as the sole member of its executive board.